// App-Quantinova.ai

TPS4146 : A multicenter pilot study of nivolumab (NIVO) with drug eluting bead transarterial chemoembolization (deb-TACE) in patients (pts) with liver limited hepatocellular carcinoma (HCC).

Researchers

Presenter

  • James J. Harding

Principal Investigators

  • Benjamin R. Tan

  • Kim Anna Reiss

  • Kabir Mody

  • Daniel Khalil

  • Hooman Yarmohammadi

  • Gregory Nadolski

  • Joseph Daniel Giardina

  • Marinela Capanu

  • Richard K. G. Do

  • Mikaela Bradley

  • Chayma Boussayoud

  • Emily Valentino

  • Taha Merghoub

  • William R. Jarnagin

  • Michael C. Soulen

  • Karen T. Brown

  • Ghassan K. Abou-Alfa

Medical Centers

  • Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Washington University School of Medicine, St. Louis, MO

  • University of Pennsylvania, Philadelphia, PA

  • Mayo Clinic, Jacksonville, FL

  • Washington University, St Louis, MO

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Doxorubicin

  • Nivolumab

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cross-Sectional

  • Cohort

Phase

  • I

Study Id's

  • NCT03143270

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved